Clinical Trial

A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-11
Trial Details
NCT Number NCT07513441
Lead Sponsor H. Lundbeck A/S
Conditions Parkinson Disease
Enrollment 10 participants
Start Date 2026-05-26
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10